Crossmark

Development of a small molecule that corrects misfolding and increases secretion of Z α <sub>1</sub> ‐antitrypsin

Crossref DOI link: https://doi.org/10.15252/emmm.202013167

Published Online: 2021-01-29

Published Print: 2021-03-05

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Lomas, David A https://orcid.org/0000-0003-2339-6979
Irving, James A https://orcid.org/0000-0003-3204-6356
Arico‐Muendel, Christopher

Belyanskaya, Svetlana

Brewster, Andrew

Brown, Murray

Chung, Chun‐wa

Dave, Hitesh

Denis, Alexis

Dodic, Nerina

Dossang, Anthony

Eddershaw, Peter

Klimaszewska, Diana

Haq, Imran

Holmes, Duncan S

Hutchinson, Jonathan P

Jagger, Alistair M

Jakhria, Toral

Jigorel, Emilie

Liddle, John

Lind, Ken

Marciniak, Stefan J

Messer, Jeff

Neu, Margaret

Olszewski, Allison

Ordonez, Adriana

Ronzoni, Riccardo https://orcid.org/0000-0002-3981-8104
Rowedder, James

Rüdiger, Martin

Skinner, Steve

Smith, Kathrine J

Terry, Rebecca

Trottet, Lionel

Uings, Iain

Wilson, Steve

Zhu, Zhengrong

Pearce, Andrew C https://orcid.org/0000-0002-4698-037X
Funding

Funding for this research was provided by:

GlaxoSmithKline

Medical Research Council (MR/N024842/1)

UCLH Biomedical Research Centre

Biotechnology and Biological Sciences Research Council (BB/T002603/1)
License Information

Version of Record valid from 2021-01-29
More Information

Publication History

Received: 2020-07-23

Accepted: 2020-12-10

Published: 2021-01-29